Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 9-Week home program sharpen memory in young people with epilepsy?

NCT ID NCT07735715

Symptom relief Sponsor: Dartmouth-Hitchcock Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Sep 11, 2026 · Updated 3 times

Summary

This trial investigates whether a home-based self-management program called HOBSCOTCH can improve thinking, memory, and quality of life in young adults (ages 18–29) and youth (ages 13–17) with epilepsy. Participants attend nine weekly one-on-one coaching sessions by phone or computer, learning problem-solving strategies and memory aids. Researchers compare survey responses before and after the program to see if cognitive function and well-being improve, and whether parents of younger participants feel less burdened.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a home-based self-management program called HOBSCOTCH that teaches problem-solving strategies and memory aids
What this could lead to
If it works, this program could offer a practical, accessible way to help young people with epilepsy manage cognitive difficulties and improve daily life.
What could go wrong
This is an early-stage trial without a control group, so improvements may be due to time or attention rather than the program itself. Results rely on self-reported questionnaires.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 29 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion Criteria for Young Adults with Epilepsy (YAWE) and Youth with Epilepsy (YWE): * Age 18 - 29 years for YAWE * Age 13 - 17 years for YWE * For YWE at least one parent or legal guardian provides consent and agrees to participate * Diagnosis of epilepsy (controlled or uncontrolled seizures) * Subjective cognitive complaints (memory, attention, learning, problem solving, executive function, planning) * Literate and proficient in English * Telephone access * Internet Access. Inclusion Criteria for Parent of Youth with Epilepsy (YWE): * Parent or legal guardian of a youth with epilepsy (age 13 - 17 years) * Literate and proficient in English * Telephone access * Internet Access Exclusion Criteria: * Active psychosis (any participant) * Illicit substance abuse (any participant) * Severe cognitive/intellectual disability (any participant) * YWE cannot participate without a parent and parent's consent (or legal guardian) * YWE cannot participate without assent even if a parent or legal guardian gives consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive dysfunction, cognitive disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cognitive disorder Cognitive Dysfunction epilepsy visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive dysfunction, cognitive disorder Epilepsy Memory and thinking problems

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dartmouth-Hitchcock

    Lebanon, New Hampshire, 03756, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.